Lack Of Funding Stalls Major US FDA Cybersecurity Initiative

A public-private partnership board long touted by top US FDA officials to help address cybersecurity threats has hit a funding wall. The agency received less than half of what it asked for in the FY 2019 budget for its digital efforts, including its cybersecurity strategy, leading it to make some tough choices.

Digital crime by an anonymous hacker - Image

Lack of congressional funding has forced the US Food and Drug Administration to scale back its Cybersecurity Medical Safety Analysis Board proposal. Instead of launching the public-private partnership board that would advise the agency on emerging and ongoing cybersecurity threats this year, the agency has only gone as far as putting together a small multi-stakeholder team to help develop the program, which may never happen.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation